Catalyst Pharmaceuticals Announces First Quarter 2016 Financial Results and Provides Corporate Update

Go back to Catalyst Pharmaceuticals Announces First Quarter 2016 Financial Results and Provides Corporate Update

Catyalyst Pharma (CPRX) Reports In-Line Q1 Loss

May 10, 2016 4:57 PM EDT

Catyalyst Pharma (NASDAQ: CPRX) reported Q1 EPS of ($0.07), in-line with the analyst estimate of ($0.07).

Upcoming 2016 Milestones

Collaboratively working with the FDA to finalize a regulatory path forward for FirdapseInitiate the confirmatory Phase 3 trial for... More